Xoma Corp. Files SEC Form 3 in Pharmaceutical Preparations

Strategic Insights -

Xoma Corp. has made a submission to the U.S. Securities and Exchange Commission (SEC) regarding its ownership in Pharmaceutical Preparations, according to a recent filing. The company, which has its headquarters located at 2910 SEVENTH ST, BERKELEY CA 94710, has a SIC code of 2834 and is registered under Section 12 of the '34 Act.

As part of the filing, the company has reported details about its director, officers, and owners holding more than ten percent of a class of equity securities. This includes information on their relationship to the company and their purchases and sales of such equity securities. The filing is a mandatory requirement for publicly-traded companies to adhere to.

Key Takeaways:

  • The SEC filing by Xoma Corp. was submitted on April 7, 2015, with the SEC file number 0000791908-15-000052.
  • The company has a SIC code of 2834, which falls under the Pharmaceutical Preparations category.
  • The contact information for Xoma Corp. is listed as 2910 SEVENTH ST, BERKELEY CA 94710, with a contact number 5106441170.
  • The filing is a part of the company's mandatory submission as a publicly-traded entity under Section 12 of the '34 Act.
  • The forms included in the submission contain information about the reporting person's relationship to the company and their transactions involving equity securities.
  • The SEC filing is a formal document submitted to the U.S. Securities and Exchange Commission, with the filing available at http://www.sec.gov/Archives/edgar/data/1638479/0000791908-15-000052-index.html.

Statistics:

  • One document was filed with Form 3 by Xoma Corp.
  • The filing was made under the SIC code of 2834.

Sources:

  • Xoma Corp. (Form 3), April 7, 2015, SEC filing.
  • U.S. Securities and Exchange Commission (SEC) (http://www.sec.gov/Archives/edgar/data/1638479/0000791908-15-000052-index.html).